AstraZeneca

  • Seroquel XR 2015 report

    Seroquel XR 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by...

  • Symbicort 2015 report

    Symbicort 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this...

  • Synagis 2015 report

    Synagis 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 18 Pages The 5 Key Questions Addressed by this Report:...

  • Tagrisso 2015 report

    Tagrisso 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Brilinta 2014 report

    Brilinta 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by this...

  • Bydureon 2014 report

    Bydureon 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Crestor 2014 report

    Crestor 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Dutoprol 2014 report

    Dutoprol 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 20 Pages The 5 Key Questions Addressed by this...

  • Farxiga 2014 report

    Farxiga 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Faslodex 2014 report

    Faslodex 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • FluMist 2014 report

    FluMist 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Nexium 2014 report

    Nexium 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 18 Pages The 5 Key Questions Addressed by this...